Virtus Investment Advisers, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus Investment Advisers, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,223,842
+5.2%
13,6620.0%0.83%
+5.4%
Q2 2023$1,163,183
+2.9%
13,6620.0%0.79%
-0.3%
Q1 2023$1,130,531
+143.0%
13,662
+130.9%
0.79%
+155.5%
Q4 2022$465,293
+6.2%
5,9160.0%0.31%
+54.2%
Q3 2022$438,0005,9160.20%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders